These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16286104)

  • 1. Correlates and prevalence of prostatitis in a large community-based cohort of older men.
    Daniels NA; Ewing SK; Zmuda JM; Wilt TJ; Bauer DC;
    Urology; 2005 Nov; 66(5):964-70. PubMed ID: 16286104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential therapeutic strategy for prostatic disease by targeting the oral microbiome.
    Fang C; Wu L; Zhu C; Xie WZ; Hu H; Zeng XT
    Med Res Rev; 2021 May; 41(3):1812-1834. PubMed ID: 33377531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
    Crocetto F; Boccellino M; Barone B; Di Zazzo E; Sciarra A; Galasso G; Settembre G; Quagliuolo L; Imbimbo C; Boffo S; Angelillo IF; Di Domenico M
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32878054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRB2-associated binding protein 2 regulates multiple pathways associated with the development of prostate cancer.
    Qiao XR; Zhang X; Mu L; Tian J; Du Y
    Oncol Lett; 2020 Oct; 20(4):99. PubMed ID: 32831918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human gastrointestinal microbiota and prostate cancer development and treatment.
    Sha S; Ni L; Stefil M; Dixon M; Mouraviev V
    Investig Clin Urol; 2020 Feb; 61(Suppl 1):S43-S50. PubMed ID: 32055753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis.
    Zhang L; Wang Y; Qin Z; Gao X; Xing Q; Li R; Wang W; Song N; Zhang W
    J Cancer; 2020; 11(1):177-189. PubMed ID: 31892984
    [No Abstract]   [Full Text] [Related]  

  • 7. The Lifetime Risk and Prognosis of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in the Middle-Aged Chinese Males.
    Zhang J; Zhang X; Cai Z; Li N; Li H
    Am J Mens Health; 2019; 13(4):1557988319865380. PubMed ID: 31311396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between oral pathogens and prostate cancer: building the relationship.
    da Silva APB; Alluri LSC; Bissada NF; Gupta S
    Am J Clin Exp Urol; 2019; 7(1):1-10. PubMed ID: 30906801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mast cells on the biological characteristics of prostate cancer cells.
    Ma Z; Yue L; Xu Z; Zeng S; Ma Y; Li Z; Li W; Wang D
    Cent Eur J Immunol; 2018; 43(1):1-8. PubMed ID: 29731687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression.
    Zhao X; Deng R; Wang Y; Zhang H; Dou J; Li L; Du Y; Chen R; Cheng J; Yu J
    Oncogenesis; 2017 Apr; 6(4):e315. PubMed ID: 28394356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up.
    Vaarala MH; Mehik A; Ohtonen P; Hellström PA
    Oncol Lett; 2016 Aug; 12(2):1149-1153. PubMed ID: 27446410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of DNA viruses in prostate cancer.
    Smelov V; Bzhalava D; Arroyo Mühr LS; Eklund C; Komyakov B; Gorelov A; Dillner J; Hultin E
    Sci Rep; 2016 Apr; 6():25235. PubMed ID: 27121729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer.
    Yang L; Gao L; Chen Y; Tang Z; Zhu Y; Han P; Li X; Wei Q
    Int J Med Sci; 2015; 12(11):853-61. PubMed ID: 26640404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle and Risk of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in a Cohort of United States Male Health Professionals.
    Zhang R; Sutcliffe S; Giovannucci E; Willett WC; Platz EA; Rosner BA; Dimitrakoff JD; Wu K
    J Urol; 2015 Nov; 194(5):1295-300. PubMed ID: 26070893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing trends in symptomatology, diagnostics, stage and survival of prostate cancer in Northern Finland during a period of 20 years.
    Kavasmaa OT; Tyomkin DB; Mehik A; Parpala TM; Tonttila P; Paananen I; Kunelius P; Vaarala MH; Ohtonen P; Hellström PA
    World J Surg Oncol; 2013 Oct; 11():258. PubMed ID: 24094418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis.
    Weight CJ; Kim SP; Jacobson DJ; McGree ME; Boorjian SA; Thompson RH; Leibovich BC; Karnes RJ; St Sauver J
    Eur Urol; 2013 Jun; 63(6):1021-7. PubMed ID: 23313032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic imbalance and prostate cancer progression.
    Burton AJ; Tilling KM; Holly JM; Hamdy FC; Rowlands MA; Donovan JL; Martin RM
    Int J Mol Epidemiol Genet; 2010 Jul; 1(4):248-71. PubMed ID: 21532839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bacteria in oncogenesis.
    Chang AH; Parsonnet J
    Clin Microbiol Rev; 2010 Oct; 23(4):837-57. PubMed ID: 20930075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostatic inflammation and prostate cancer].
    Bastian PJ; Nuhn P; Stadler TC; Roosen A; Stief CG
    Urologe A; 2010 May; 49(5):636-8. PubMed ID: 20405276
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.